Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production

NCT ID: NCT07061730

Last Updated: 2025-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to determine whether the hybrid model improves articulation in children more effectively than traditional SLP-only therapy. Over the course of 8 weeks, participants will receive weekly therapy sessions, and those in the hybrid therapy group will also practice with Jessica between sessions. The study will also gather feedback from parents and speech therapists to assess their experiences and satisfaction with treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The RCT compares two intervention conditions over eight weeks: (1) a hybrid treatment group, where children receive one weekly "treatment as usual" clinician-led tele-practice session PLUS an additional 60 minutes of home practice with Jessica, and (2) a traditional treatment group, where children receive one weekly "treatment as usual" clinician-led tele-practice session.

Children from both groups will be assigned to work on either the /ɹ/ or /s/ sound for the duration of the study, depending on their clinical needs. Children are randomized to conditions and stratified by clinicians. The investigators expect to enroll 100 children, 50 in each condition, aged 5-17 from the following states where study-trained SLPs hold valid clinical licenses: CO, NC, WA, KS, MS, IN, MN, MT, AK, NV, OH, VA, FL, GA, AZ, LA, NY, NJ, MI. Participants must be children aged 5;0 to 17;11 who speak American English as a primary language, have no significant cognitive, neurological, or structural speech impairments, score at or below the 10th percentile on the Goldman-Fristoe Test of Articulation-3 (GFTA 3), have a desire to change their production of /ɹ/ or /s/, and have access to broadband internet for telepractice. Participants with autism, Down syndrome, cerebral palsy, intellectual disabilities, epilepsy, significant hearing loss, ADHD, Tourette's, OCD, or orthodontic appliances that block the roof of the mouth are excluded from this clinical trial phase.

The investigators hypothesize that the hybrid treatment group will show greater improvement in speech sound learning compared to the traditional group, as measured by expert perceptual ratings of unpracticed words. Additionally, it is expected that children in the hybrid group will achieve mastery of targeted speech sounds in fewer sessions, making speech therapy more efficient and cost-effective. If successful, this study could provide strong evidence supporting the integration of AI-driven home practice into standard speech therapy protocols, leading to broader accessibility and improved outcomes for children with SSDs. Furthermore, an analysis of treatment fidelity and participant engagement with Jessica will offer insights into the practical implementation of AI-assisted speech therapy in real-world clinical settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Speech Sound Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional Therapy

The child will receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where the child will work on speech sounds with direct feedback from the SLP.

Group Type ACTIVE_COMPARATOR

Traditional Therapy

Intervention Type BEHAVIORAL

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP.

Hybrid Therapy

The child will receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where the child will work on speech sounds with direct feedback from the SLP. In addition to these weekly sessions, the child will practice using the AI-based speech therapy tool, Jessica, at home between sessions for 60 minutes per week. The tool will provide real-time feedback on the child's articulation and track their progress. The child will be asked to practice specific speech exercises, such as producing target sounds (e.g., /r/, /s/) in words, phrases, or sentences.

Group Type EXPERIMENTAL

Hybrid therapy

Intervention Type BEHAVIORAL

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP. In addition to these weekly sessions, the child will practice using the AI-based speech therapy tool, Jessica, at home between sessions for 60 minutes per week. The tool will provide real-time feedback on the child's articulation and track their progress. The child will be asked to practice specific speech exercises, such as producing target sounds (e.g., /r/, /s/) in words, phrases, or sentences.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional Therapy

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP.

Intervention Type BEHAVIORAL

Hybrid therapy

The child would receive standard speech therapy, meeting with the SLP once a week for therapy sessions for 8 weeks. These sessions will focus on articulation practice, where your child will work on speech sounds with direct feedback from the SLP. In addition to these weekly sessions, the child will practice using the AI-based speech therapy tool, Jessica, at home between sessions for 60 minutes per week. The tool will provide real-time feedback on the child's articulation and track their progress. The child will be asked to practice specific speech exercises, such as producing target sounds (e.g., /r/, /s/) in words, phrases, or sentences.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Response to be filled out by the Parent after sign up.

* Does the child speak American English as one of their primary languages: Yes
* At what age did the child first begin to learn English? Age 4 or younger
* Child's current age: \> 5 years or \< 17 years 8 months
* Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: NO
* Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? NO
* Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? NO
* Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? NO
* Is one of your goals for your child to work on saying the "r" or "s" sounds? YES

Exclusion Criteria

* EXCLUSIONARY Response to be filled out by the Parent after sign up.
* Does the child speak American English as one of their primary languages: No
* At what age did the child first begin to learn English? Age 4 or older
* Child's current age: \<5 years or \> 17 years 8 months
* Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: YES
* Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? YES
* Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? YES
* Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? YES
* Is one of your goals for your child to work on saying the "r" or "s" sounds? NO
Minimum Eligible Age

5 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Better Speech

OTHER

Sponsor Role collaborator

Syracuse University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Nehlig

Role: STUDY_DIRECTOR

Better Speech

Ranan Lachman

Role: STUDY_DIRECTOR

Better Speech

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Syracuse University

Syracuse, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonathan Preston

Role: CONTACT

315-443-3013

Nina Benway

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonathan Preston

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Privately Funded

Identifier Type: OTHER

Identifier Source: secondary_id

GENESIS-25-065

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Speech Signals in Stuttering
NCT05668923 RECRUITING NA